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aBstraCt
The article aims at presenting a legal basis for corneal transplantation — the most frequently conducted 
transplantation procedure in Poland. Applicable rules and regulations concerning transplantation can be found 
in the Cell, Tissue, and Organ Recovery, Storage, and Transplantation Act of July 1, 2005 and the Regulation 
of the Minister of Health of December 4, 2009 on detailed conditions of removal, preservation, and transplan-
tation of cells, tissues, and organs. However, the scope and content of the above legislation does not directly 
refer to corneal transplantation, neither in concept nor description, which may lead to certain misinterpreta-
tions and ambiguity of information as to the adopted rules of corneal removal, transplantation and the existing 
formal solutions (documentation, or rules for obtaining consent). The article refers to a very important legal 
principle — omnia sunt interpretanda — which in practice obliges the description and proper interpretation of 
the legal rules pertaining in this content to such procedures. In terms of legalisation it is possible to find only 
norms concerning the possibility of obtaining and transplanting corneas, entities which can conduct such pro-
cedures (after obtaining the consent of the Ministry of Health), and information on the scope of the so-called 
presumed consent that is one of the basic legal mechanisms allowing tissue procurement from deceased donors. 
The summary is a synthetic and comprehensive presentation of current knowledge and the legal situation of 
corneal transplantation, which can prove useful in an appropriate interpretation of legal standards regarding 
such procedures.
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introduCtion 
According to statistics from 2014, there were 
2055 organ transplants conducted in Poland al-
together (1120 kidney, 336 liver, 76 heart, and 
19 lung transplants) [1]. In December 2014, there 
were 2638 registered recipients waiting for a corne-
al transplant [2], and there were 939 and 884 cor-
neal transplants in 2014 and 2015, respectively 
[1]. In Poland, the number of people with visual 
impairment exceeds 500,000. Data indicate that 
nearly 1% of the world’s population has serious 
vision impairments, and the total number of blind 
and partially sighted is still growing [3]. Many 
people suffer from corneal damage, which at the 
current state of medical knowledge and technology 
can be treated through transplantation. Corneal 
transplantation does not require the donor to be 
immunologically compatible with the recipient; 
however, the success of the transplant depends on 
the quality of the donor’s cornea prior to surgery, 
the quality of the donor’s tissue, and the equip-
ment used. The cornea is usually taken in the form 
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of a corneal-scleral flap and is placed in a special 
preservative fluid, which allows for safe storage 
and transport of the collected tissue [4]. A corne-
al transplant can be partial or full thickness [5], 
and the graft is taken from a deceased donor [4]. 
The tissue from adult donors must be collected 
within 12–18 hours after death. The corneas from 
infants and children under three years old are taken 
extremely rarely due to surgical and refractive prob-
lems as well as high probability of transplant rejec-
tion. Corneas after procurement but before trans-
plantation are stored in the Eye Tissue Bank (BTO, 
Bank Tkanek Oka), where the assessment of tissue 
suitability of the graft, including molecular and se-
rological testing of the donor’s blood, is carried out 
in order to rule out factors that would disqualify 
the deceased as a potential donor. The medical his-
tory interview conducted for this purpose initiates 
the procedure of obtaining corneas for transplant 
and includes: verifying the existence or the lack of 
an objection in the Central Register of Objections 
(CRS, Centralny Rejestr Sprzeciwów), checking 
for any other forms of objections, an analysis of the 
donor’s medical records, an interview with a per-
son who can provide detailed information about 
the donor (in case of a deceased donor), and an 
interview with the doctor who treated the donor 
(including an interview with a primary care physi-
cian). The results of a biopsy of the potential donor 
are thoroughly analysed with the ultimate cause of 
death. In this case, the medical interview pertains 
to the analysis of the following [6]: 
•	 report of post-mortem examination (autopsy re-
sults are available approximately one to two days 
after tissue procurement);
•	 results of physical examination (body inspec-
tion) of the deceased in order to detect any con-
ditions that would rule him/her out as a donor;
•	 medical records concerning the evaluation of 
medical state of the donor for the suitability of 
the collected tissue [7];
•	 other criteria that would exclude the potential 
donor’s tissues or cells on the basis of detailed 
information [8].
The study of the donor’s blood includes sero-
logical and molecular tests for the presence of HIV 
1 and 2, anti HIV 1 and 2, hepatitis B HBsAg and 
anti-HBc, and hepatitis C: anti HCV and serolog-
ical tests for syphilis. It is also necessary to perform 
the following tests [8]:
•	 test for HTLV-1 antibodies among donors living 
in areas with high morbidity or who come from 
such areas or whose sexual partners or parents 
originate from such areas;
•	 in case of a positive anti-HBc test and a negative 
HBsAg test it is necessary to evaluate further 
risks, determining the suitability of the procured 
tissue for clinical use;
•	 depending on the data found in the donor’s 
medical records and the characteristics of the 
procured cells or tissues, the donor should 
undergo additional tests such as for the RhD 
and HLA antigen towards malaria, CMV, tox-
oplasmosis EBV, and the Trypanosoma cru-
zi protozoa.
Standard surgical procedures associated with 
cell or tissue retrieval are also determined: the 
manner in which the above are collected and 
transferred to the receiving entity, equipment 
used for transplants, specialist packaging, mark-
ing, method of identification, etc. [8]. Harvested 
corneas undergo microscopic examination, in-
cluding the density of endothelial cells. Donor’s 
corneas are stored in a temperature above 4°C for 
up to 14 days or in tissue cultures (even up to six 
weeks) [8]. 
Current LegaL situation — anaLYsis
In interpreting the current legal status, i.e. pro-
visions related to the possibility of transplantation 
of the cornea, it should be noted that the very 
concept of the cornea does not occur as a direct 
medium with defined and assigned legal norms or 
standards. In this case, for the legal analysis it is 
necessary to apply a definition that will expand its 
designation. The review and analysis of European 
and national legislation conducted in the further 
parts of the article will allow for the presentation 
of the most important issues concerning corneal 
donation, rules for its storage, and the accompa-
nying formal-legal solutions. Simultaneously, in 
connection with the adoption of the interpreta-
tion of the cornea, as human tissue, wherever the 
word “tissue” is used (directly or in the context) 
by extension of concepts it will be identified with 
the cornea.
european reguLations
The most important Act of European priority is 
Directive 2004/23/EC of the European Parliament 
and of the Council of 31 March 2004 on setting 
standards of quality and safety for the donation, 
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procurement, testing, processing, preservation, 
storage, and distribution of human tissues and 
cells. This Directive, on a community level, de-
termines and legalises transplants, provides basic 
rules of recipient security, protects sensitive data 
of both donors and recipients, and delivers ba-
sic principles related to the functioning of tissue 
banks. In the broad scope, the Directive concerns 
tissues and cells, including haemopoietic stem cell, 
umbilical cord blood, bone marrow stem cells, 
reproductive cells (oocytes, sperm), foetal tissues 
and cells, and adult and embryonic stem cells [9]. 
This Act states and provides legal basis for trans-
plantations, determining that the tissues and cells 
used for allogeneic therapy can be collected from 
living as well as dead donors, and provides the 
requirement of medical examination prior to in-
tervention. The next essential principle of this act 
specifies that, because it is crucial to respect the 
dignity of the dead donor, after material harvest-
ing it is necessary to reconstruct the body so that 
it is as close as possible to its original anatomical 
shape. In the Directive, tissues are defined as all 
the components of the human body formed by 
cells, and the donor is defined by any type of living 
or dead source of human tissues and cells. Tissue 
banks are facilities that conduct activities relat-
ed to the processing, preservation, storage, and 
distribution of human tissues and cells, and they 
can also be responsible for the procurement of 
tissues. The Directive pays much attention to the 
obligation of data protection and security, mainly 
the protection of donor’s data and the protection 
of other data obtained during transplantation. It 
postulates the introduction of security measures 
against unauthorised disclosure, removal, or any 
modifications in the medical documentation [9]. 
Another important act is the Commission Direc-
tive 2006/17/EC of 8 February 2006 implementing 
Directive 2004/23/EC of the European Parliament 
and of the Council as regards certain technical re-
quirements for the donation, procurement, and testing 
of human tissues and cells. This Directive in turn, 
concerns mainly medical issues associated with lim-
iting the risk of disease transfer or other potential 
threats to the recipient [10]. This risk is decreased 
through the introduction of careful donor selection 
and analysing tissue procurement procedures and 
their consistency with the principles and process-
es of realising the idea based on the best avail-
able scientific knowledge. Additional protection 
is provided by the introduction of the so-called 
standards of surgical procedures based on the ver-
ification of the following information: the donor’s 
identity, donor’s consent or family authorisation, 
evaluation of the criteria for donor selection, and 
the evaluation of laboratory tests required for in-
dividual donors. Basic criteria for donor selection 
are based on the analysis of risks associated with 
the use of harvested tissue. Their rates are deter-
mined through physical examination, the analysis 
of medical history, community interview, biological 
research and post-mortem examination (in cases 
of deceased donors). General exclusion criteria for 
deceased donors include [10]:
•	 unknown and unspecified cause of death;
•	 disease of unknown aetiology;
•	 cancer except for primary basal cell carcinoma, 
carcinoma in situ of the cervix, and some prima-
ry tumours of the central nervous system that 
have to be assessed according to current scien-
tific knowledge;
•	 the risk of transmission of diseases caused by 
prions (e.g. people diagnosed with Creutzfeldt-
Jakob disease);
•	 systemic infection that is not controlled at the 
time of donation (bacterial, viral, fungal, or par-
asitic infection in the tissues and cells that are to 
be harvested);
•	 a history, or clinical or laboratory evidence of 
HIV infection, acute or chronic hepatitis B (ex-
cept for those with a proven immune status), 
hepatitis C, and HTLV I/II;
•	 chronic, systemic autoimmune disease that 
could have a detrimental effect on the quality of 
the tissue to be harvested;
•	 invalid results of donor blood samples (occur-
rence of haemodilution, treatment with immu-
nosuppressive agents);
•	 evidence of other risk factors associated with 
infectious diseases;
•	 presence of physical signs on the donor’s body 
implying a risk of infectious disease (diseases) as 
described in Annex IV, point 1.2.3;
•	 intake of, or exposure to, substances such as cy-
anide, lead, mercury, gold;
•	 vaccination with a live attenuated virus, in an 
interview, if there is a risk of transmission;
•	 the use of xenografts.
What needs emphasis is the fact that donors 
with malignant diseases may be evaluated and con-
sidered for cornea donation, except for those with 
retinoblastoma, haematological neoplasm, and ma-
lignant tumours of the anterior segment of the eye-
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ball. Also, donors with bacterial septicaemia may be 
evaluated and considered for eye donation but only 
where the corneas are to be stored in organ culture 
to detect any bacterial contamination of the collect-
ed tissue [10].
nationaL reguLations
The Act of 1 July 2005 on the collection, stor-
age, and transplantation of cells, tissues, and organs 
defines the rules for the collection, storage, and 
transplantation of cells, including haematopoietic 
cells of the bone marrow, peripheral blood and 
umbilical cord blood, tissues, and organs derived 
from a living donor or a cadaver [7]. The Act deter-
mines the source of the tissue as the living or dead 
donor from whom the cells, tissues, and organs are 
to be collected. The tissue is defined as a set of cells 
with specialised functions connected with each oth-
er by an intercellular substance. The Tissue Bank 
(Eye Tissue Bank) is defined as an organisational 
unit responsible for the collection, processing, ster-
ilisation, storage, and distribution of tissues and 
cells. The Act allows and suggests the possibility 
of collecting cells, tissues, or organs from cadavers, 
which is basic for cornea harvesting. It should be 
stressed that this Act establishes a legal classification 
of the possibility of harvesting, or in the colloqui-
al sense, depriving cadavers of anatomical parts 
in special situations (the harvested “part” will be 
used to save lives or improve the quality of health 
of another human being). Cells, tissues, or organs 
can be taken from human corpses for diagnostic, 
therapeutic, research, and teaching purposes. What 
is very important — in the absence of a legal basis, 
ridding the body of any integral part would be 
a form of profanation (and even a specific form 
of theft) associated with the desecration and lack 
of reverence for the dead, which naturally would 
be punishable by law. Therefore, this Act legalis-
es the process of transplantation. This document 
also sets out a very important element associated 
with formal legality of organ donation; namely, it 
introduces the concept of the so-called presumed 
consent [7]. 
The principle of presumed consent implies that 
anyone who during his/her lifetime did not ob-
ject in an established manner to organ and tis-
sue donation agrees to donate his/her organs after 
death. From the perspective of legal norms, it is 
an agreement for something (removal of tissue) 
that will take place in an unspecified future (after 
death), i.e. without the awareness of self-determi-
nation (determination as to one’s own body or its 
components). The adopted principle relies on an 
idealistic assumption that every person “agrees” 
to donate their organs and tissues after death, so 
that those organs/tissues can save lives and re-
store health of others. However, an opposite situ-
ation may occur where there is no consent for 
organ/tissue donation after death. In such a case, 
it is possible to express objection, which will be 
in force after death. Any objection, expressed in 
a previously established way, will not allow doctors 
(after verification of its possible forms) to continue 
with organ/tissue transplantation. The construc-
tion of presumed consent has rational and practi-
cal reasons and motivations. It rationally assumes 
that with the individual’s death “organs/tissues are 
no longer needed” and those organs/tissues may 
function in a different body. In a practical di-
mension the doctor intending to harvest organs 
or tissues checks whether there is no objection in 
the CRS (Central Register of Objection) (www.
poltransplant.org.pl/form_main.html). If there is 
no record of any objection in the CRS held by 
Poltransplant, or there is no appropriate statement 
(written or oral filed earlier in the presence of 
witnesses and confirmed by them in writing) the 
process of organ/tissue harvesting and storing can 
begin (cornea). It should be underlined that the 
law allows for the creation of a document (writ-
ten declaration), which will clearly and explicitly 
inform that the person who signed it does not 
allow the use (harvesting) of his/her organs in 
case of death (including brain death) for the pur-
pose of transplantation. In real life situations such 
a statement may cause certain difficulties: first of 
all these statements should be carried with the 
potential donor constantly and the finding and 
verification of such documents by the medical staff 
is time consuming and may postpone procure-
ment. Additionally, it raises further issues related 
to e.g. where such a document should be kept. 
As to the mentioned oral statement of objection, 
the Act determines that the collection of cells, tis-
sues, or organs from cadavers for their further trans-
plantation can be done if the deceased person did 
not express an oral objection (lack of consent for 
organ donation) in the presence of two witnesses 
and confirmed by them in the form of a signature. 
This is specified by article 6, paragraph 1 of the Act 
of 1 July 2005 on the collection, storage, and trans-
plantation of cells, tissues, and organs. The provisions 
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of paragraph 1 are also applied to the objection ex-
pressed by the legal representative. The established 
forms of objection such as personally signed state-
ment and an oral statement made in the presence 
of at least two witnesses in the practice constitutes 
and essential problem for facilities storing corneas 
(tissue banks) [7]. The problem is to determine, 
apart from when the objection was made in the 
Central Objection Registry, whether there were 
any other forms of objections as found in point 
2 and 3 (point 2 requires a written statement of 
objection for organ harvesting, but the practice 
and reality, or the necessity of searching for such 
a statement shows that the implementation of this 
structure is problematic). Additionally (point 3), 
when the donor’s family questions the circum-
stances of organ harvesting and summons the do-
nor’s oral objection as to the donation of organs, 
cornea in this case, it is also problematic. The 
problem of the interpretation of presumed consent 
requires a broader analysis that exceeds the subject 
of this study. The above-mentioned Central Reg-
istry of Objection for harvesting cells, tissues, and 
organs is kept by the Organisation-Coordination 
Centre – “Poltransplant” [7], and in order to place 
an objection the person who wishes to do so needs 
to provide the following information [7]:
•	 name and surname;
•	 date and place of birth;
•	 social security number, if there is one (this data 
is stored for a period of five years from the date 
of death of the person objecting, and after expiry 
of that time they are destroyed to prevent iden-
tification);
•	 address and place of residence (data stored for 
a period of five years from the date of death of 
the person objecting, and after expiry of that 
time they are destroyed to prevent identifica-
tion);
•	 date when, and place in which, the objection was 
made or withdrawn;
•	 the date of obtaining the notification of objec-
tion.
Information from the Central Register of Ob-
jections shall be provided immediately after re-
ceiving questions from the physician intending to 
harvest organs or a person authorised by him/her 
(www.poltransplant.org.pl/pozwolenia.html). An 
extremely important aspect is the criteria of brain 
death because these criteria and the overall defini-
tion of brain death determined by the transplanta-
tion act has evolved over time. The transplantation 
act prior to amendments (before 2009) states that 
death occurs with the permanent, irreversible ces-
sation of the brain stem, the so-called death of the 
brain stem. The new law defines the death of an 
individual by the death of the individual’s whole 
brain, i.e. permanent and irreversible cessation of 
brain functions (the definition has been broadened 
from brain stem to the whole brain with the intro-
duction of the circulatory criteria — article 9a) [7]. 
According to the majority of medical stances, the 
death of the brain is equivalent to the death of an 
individual. The cornea is harvested from cadavers, 
and the “type of death” is irrelevant, i.e. whether 
it occurred naturally, was an outcome of an ac-
cident, outcome of a disease, or whether brain 
death was declared. The Act also introduces another 
important legal principle: professional confidenti-
ality. Personal data of the potential recipient are 
confidential and protected under the provisions of 
professional confidentiality, provisions on medical 
records kept by medical entities, and provisions 
on personal data protection [11–13]. According 
to regulations, storage of corneas in tissue and cell 
banks is possible after the facility obtains permis-
sion from the Ministry of Health to conduct such 
procedures. This permission is granted for a period 
of five years by the Minister of Health at the request 
of the National Centre for Tissue and Cell Bank-
ing, after an opinion issued by the National Coun-
cil of Transplantation. The cell and tissue bank 
obtains such permission if it meets the following 
requirements [7]: 
•	 it employs qualified personnel, including the 
person responsible for compliance with the legal 
regulations and rules determined in the quality 
assurance system;
•	 it has facilities and equipment meeting profes-
sional and sanitary requirements;
•	 it presents a draft of a quality assurance system 
(establishing in detail the methods of moni-
toring cells and tissues, surveillance of transfer 
conditions between donor and recipient, and 
the quality of all medical devices and materi-
als, which have direct contact with those cells 
and tissues).
The application for permission should be ac-
companied by information on the number of em-
ployees, their qualifications, the opinion of the 
local health inspector on the fulfilment of the re-
quirements found in the regulations, list of rooms 
and facilities, organisational structure of the bank, 
responsibilities of bank employees, and the pos-
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sibility to foresee the scope of activities and the 
list of entities with which the bank will collabo-
rate based on a written agreement. Cell and tissue 
banks are required to collect and keep medical 
records on the stored and issued cells and tissues 
for at least 30 years from their date of issue for 
transplantation, in a manner that will allow iden-
tification of both donors and recipients. The doc-
umentation can also be stored in electronic form. 
It is necessary to note that the storage time for 
medical documentation in the bank is established 
for 30 years, which is longer than the usual re-
quirement of storing medical documentation, i.e. 
20 years (with exceptions) [14]. The above-men-
tioned permit of the Minister of Health to store 
the corneas in the tissue and cell banks has a very 
wide range and may include:
•	 transplantation of corneas from deceased do-
nors;
•	 harvesting the corneal limbus from a living do-
nor and its auto- and allogeneic transplantation;
•	 transplantation of the cornea and corneal limbus 
from deceased donors;
•	 amniotic membrane transplantation;
•	 transplantation of the cornea and sclera frag-
ments from a deceased donor.
The executive Act to the mentioned law is 
the Minister of Health regulation of 4 December 
2009 concerning detailed conditions of harvest-
ing, storage, and transplantation of cells, tissues, 
and organs [15]. The Regulation defines profes-
sional qualifications of people (including coordi-
nators) receiving cells, tissues, and organs, as well 
as the people who conduct transplantations. The 
Regulation also indicates conditions that should 
be met by entities responsible for storing of the 
harvested tissues, cells, and organs, the require-
ments as to the medicinal entities performing 
transplants, and the requirements to be met by 
medical documentation concerning the collec-
tion, storage, and transplantation of cells, tissues, 
and organs. The most important rule in the regu-
lation states that the only ones allowed to retrieve 
cells and tissues from human corpses are doctors 
and procurement teams. Cells and tissues from 
cadavers can be taken for transplantation in health 
care facilities (in medical entities, according to 
the new terminology) with an operating or autop-
sy room, forensic medicine centres, pathological 
anatomy departments of universities with medical 
divisions, and research facilities with an autopsy 
theatre. Medical documentation on the collection 
of cells, tissues, and organs, and their storage and 
transplantation include:
•	 a donor card containing the following elements: 
identity of the donor, i.e. name and surname. 
If there is a mother and a child included in 
the donation, then also the full name of the 
child; date of birth; social security number (if 
assigned); age; sex; medical history (if available); 
community interview (if it is possible to carry 
one out); the result of a physical examination; 
type of applied haemodilution; the result of clin-
ical or post-mortem examination and, in the 
case of cells or tissues that cannot be stored for 
long periods of time, the verbal result of a pre-
liminary autopsy; results of laboratory tests and 
other studies [6];
•	 recipient card specifying: recipient’s identity (full 
name); date of birth; social security number; age; 
gender and description of the transplantation of 
cells, tissues, or organs;
•	 reports concerning serious adverse events and se-
rious adverse reactions and steps taken to resolve 
them and prevent them in the future [15];
•	 documentation of inspection in the case of the 
above events, including inspection records and 
a list of measures taken to eliminate irregularities;
•	 records of collected, stored, and transplanted 
cells, tissues, and organs, containing data about 
the potential or real donor, a potential or real re-
cipient, the place and time of procurement, data 
about the doctor responsible or a person author-
ised by him/her for the organ/tissue retrieval, 
the results of all performed tests, data on the 
preparation and storage, unique ways of marking 
(ISBT 128), and confirmation of issuing of cells, 
tissues, or organs to the physician responsible 
for the transplant. ISBT 128 standard relates to 
methods for identification, labelling of blood 
and blood components, as well as of human 
tissues and organs [16].
The above documentation can also be created, 
stored, and made available in an electronic version. 
The main medical indications for corneal transplant 
include the absence of the optical function in the 
current cornea, the development of a specific disease 
that contributed to the destruction of the cornea 
and intractable inflammation. Specifically, they per-
tain to the following diseases [17]:
•	 keratoconus;
•	 corneal ecstasy;
•	 anterior corneal dystrophy;
•	 stromal corneal dystrophy;
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•	 Fuchs’ dystrophy;
•	 other corneal dystrophies;
•	 traumatic scars;
•	 other scars on the cornea;
•	 bullous keratopathy;
•	 other degenerative states of the cornea;
•	 keratitis;
•	 endosperm;
•	 other corneal opacities;
•	 corneal ulceration;
•	 corneal malacia;
•	 threatening perforation of the cornea;
•	 corneal perforation;
•	 congenital abnormality of the cornea;
•	 decompensation of the transplanted cornea flap;
•	 other disease of the cornea.
The terms of qualifying the patient for cornea trans-
plantation are determined in the National Waiting 
List. In turn, the allocation rules are closely related 
to the classification of patients for the transplant and 
their position on the waiting list. The allocation can 
be done in two modes: urgent or scheduled. Patient 
selection is carried out in medical entities dealing 
with corneal transplants, which have obtained prior 
permission from the Minister of Health. The first 
condition of receiving a transplant is to be enrolled 
on the active waiting list (www.rejestry.net). The 
list has nationwide coverage and is the only form 
of confirmation that a patient is waiting for a cor-
nea, along with information on the urgency of the 
transplantation [17]. The date of being enrolled on 
the waiting list is the time from which the waiting 
period begins. As mentioned above, there are two 
modes of indication for transplantation: urgent and 
scheduled. The urgent mode requires that at least 
one of the following criteria is fulfilled [17]:
•	 corneal disease occurring in patients under 
18 years of age;
•	 perforation of the cornea or hernial protrusion 
of Descemet’s membrane;
•	 acute inflammation of the cornea with necrosis;
•	 corneal oedema which may result in fibrotic 
stroma among patients eligible for endotheli-
al keratoplasty;
•	 corneal disorders giving corrected visual acuity 
of 0.1 or less in the better eye or only in one eye.
The urgent mode requires the updates of recipi-
ent data every seven days. Criteria for selecting the 
recipient (order criteria) are as follows [17]:
•	 first, priority is given to recipients under 18 years 
of age. If there is more than one person fulfilling 
this criterion, the first to get the transplant is the 
person who has been waiting the longest. The 
distribution of the corneas from the tissue bank 
has in these cases both local and national scope;
•	 second, priority is given to patients from the 
urgent mode from indications provided in sub-
paragraphs b, c, d, and e. From this list, priority 
is given to those who have been waiting for the 
transplant the longest. The distribution of the 
corneas from the tissue bank has in these cases 
both local and national scope;
•	 in the third place, the transplants are offered to 
patients who were scheduled for the procedure. 
From this list, priority is given to those who are 
waiting the longest. The distribution of the cor-
neas from the tissue bank has in these cases both 
local and regional scope.
The distribution of corneas by eye banks is guid-
ed by three principles:
•	 distribution on a national scale: the cornea is 
sent to the recipient enrolled on the waiting list, 
to any centre in the country;
•	 regional distribution: the grafted cornea is sent to 
the recipient who is within the bank’s region [17];
•	 local distribution: the cornea is given to the re-
cipient from the centre that harvested the cornea 
(only one of the collected pairs of corneas can be 
distributed locally).
After sending the corneas, the centre that deals 
with transplantations and Poltransplant draws up 
a protocol of allocation and distribution [17]. The 
bank can provide two corneas to the transplantation 
centre, just in case there is a need to use both (safety 
transplant). If the second cornea is to be used for 
a different recipient, the centre choses a recipient 
based on medical criteria and waiting time according 
to the table from the Poltransplant webpage (among 
recipients qualified for corneal transplant within 
the centre). The centre, which obtained two layered 
grafts from one cornea, choses a second recipient 
based on the above-mentioned criteria and accord-
ing to the table of sequence on the Poltransplant 
webpage and among recipients qualified for trans-
plantation within that centre. After transplantation, 
the centre makes an entry in the transplant registry 
and sends a protocol on choosing a particular recipi-
ent to both Poltransplant and the Tissue Bank. 
the Current situation reLating to 
CorneaL transpLants
According to available national data, the number 
of corneal transplants performed in the years be-
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tween 2007 and 2013 in Poland was 5641 procure-
ments and 4961 transplants. In 2014 and 2015 it 
was 1823 transplants and in 2016 (until august) it 
was 444 [18, 19]. Data on: conducted transplants, 
harvesting of eye tissue, and distribution of corneal 
transplants in 2010–2016 are shown in Table 1. 
A summary of the corneal-scleral rings and eyeball 
tissues harvested by the Eye Tissue Bank in the years 
between 2008 and 2015 are shown in Table 2.
end notes 
The presented legal solutions are to normalise 
and determine in a functional and rational way this 
innovative field of medicine, i.e. transplantation. 
With the possibility of corneal transplantation, legal 
norms, which in their scope are to pertain to this 
specialist medical procedure, had to be established. 
Therefore, the assumption of readability in recep-
tion, both for recipients and for persons engaged 
in this type of treatment, i.e. doctors, must be fully 
guaranteed. In the described legal acts, a great deal 
of emphasis is placed on the donor’s medical tests 
so that the tissue is safe for transplant, on the rules 
relating to the storage of the procured tissue, and 
the simplicity of the transplantation process. The 
rules also regulate the issues of protection and the 
safety of transplantation procedures, including con-
fidentiality, and the rules pertaining to keeping and 
protecting patients’ medical records. The process 
associated with the collection and storage of corneas 
in the eye tissue banks was limited by legislature 
to a formal method of obtaining the Minister of 
Health’s consent for such activities. The corneal 
donation usually comes down to the procurement 
of this tissue from the cadaver (permission for trans-
plantation of corneas needs to be granted by the 
Ministry of Health). Therefore, in such a case there 
is a necessity to remember the applicable principles 
of respect for the deceased, which are also enu-
merated and marked in the regulations. Another 
issue to be addressed is presumed consent, which in 
practice may and does cause interpretational prob-
lems (and usually manifests itself as the family’s 
objection). Lack of objection in the Central Reg-
istry of Objections allows the doctor to initiate the 
procurement process; however, other possible and 
difficult-to-verify forms of objection can hinder and 
Table 1. Number of corneal transplants (n) in Poland between 2010 and 2016
Year 2010 2011 2012 2013 2014 2015 2016 (until August)
n 623 905 855 833 939 884 444
Table 2. Data concerning tissues and eyeballs in the years between 2008 and 2015 harvested by the Eye 
Tissue Bank in Poland
Year 2008 2009 2010 2011 2012 2013 2014 2015
A 605 771 716 1294 1102 1140 1219 1057
Year 2008 2009 2010 2011 2012 2013 2014 2015
B 187 256 228 214 145 154 176 –
A — summary of the corneal-scleral rings harvested by the Eye Tissue Bank in the years between 2008 and 2015; B — summary of the eyeballs harvested by the Eye Tissue Bank in the 
years between 2008 and 2014
Table 3. Data concerning harvesting of eye tissue and the distribution of corneas in the years between 
2010–2015 
Year Number of donors of eye 
tissues
Number of harvested eye 
tissues 
Number of transplants of 
corneas authorised for 
distribution
Number of corneas dis-
tributed among hospitals
2010 480 716 816 623
2011 652 1294 1177 905
2012 559 1104 870 855
2013 579 1140 897 833
2014 614 1219 964 939
2015 533 1057 844 821
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block the process. It seems that the scope of the 
presumed consent in its practical interpretation is 
highly limited by the occurrence of situations re-
ferred to in Article 6, Paragraph 1, Point 2 and 3 of 
the Cell, Tissue, and Organ Recovery, Storage, and 
Transplantation Act of July 1, 2005. Therefore, it is 
a possible foundation for discussion of the develop-
ment of a different type of consent (an alternative, 
family consent), which would clarify the family’s 
instruction as to obtaining the corneal tissue. 
Full commercialisation, i.e. paid corneal trans-
plants, is not allowed in Poland. It is an illegal 
activity defined by articles 43 to 46b of the cited 
Act. There, according to article 44, whoever, in or-
der to obtain material or personal benefit, acquires 
and disposes of someone’s tissue, mediates in the 
purchase or sale of, or is involved in transplanta-
tion or provides tissues obtained against the provi-
sions of the Act from a living or dead donor, may 
be imprisoned from six months to five years. The 
whole process, from the moment of procurement 
(of the qualified corneas) through its storage, issu-
ing, and transplantation, is described and formally 
defined. After the procurement, a cornea must be 
transferred to one of the seven eye tissue banks. In 
the tissue bank, the corneas undergo extensive and 
multi-faceted tests, the results of which make them 
eligible for transplantation. The doctor responsible 
for transplantation needs to order from the eye tis-
sue bank a cornea suitable for his/her patient, who 
is on the waiting list and meets relevant medical 
criteria [7]. The procedure is entirely funded by 
the National Health Fund within the framework of 
individual tenders and contracts. It should be noted 
that the funds for financing corneal transplant (until 
June 2009) came from two sources: the Ministry of 
Health (highly specialised services) and the National 
Health Fund. Since 2009, the procedure (excluding 
keratectomy) is not financed by the Ministry of 
Health but from the National Health Fund in the 
context of services in the field of “hospital treat-
ment” [20]. In 2013, the Ministry of Health an-
nounced a contest for the years 2011 to 2020 under 
the title “National Program for the Development of 
Transplantation Medicine” in the scope concerning 
corneal transplants among patients at risk of graft loss 
from immunological causes, which may suggest the 
return to the financing or co-financing of the corneal 
transplants by the Ministry of Health. The conclu-
sion of the analysis is the statement that the law that 
governs this medical treatment must be very precise 
in its dimension and must be subjected to a specific 
evolution in response to the widespread expectations 
for this form of assistance to patients in need.
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